Bangladesh vs Cyprus: Hepatitis B surface antigen (HBsAg) prevalence
Bangladesh
0.4%
in 2024
Cyprus
0.5%
in 2024
Bangladesh rank
62nd
Cyprus rank
59th
Hepatitis B surface antigen (HBsAg) prevalence over time
- Bangladesh
- Cyprus
How they compare
Cyprus currently reports 0.5% against 0.4% in Bangladesh, a difference of 0.1%.
That makes Cyprus's figure about 1.2 times Bangladesh's.
The two have swapped places 3 times across 10 shared years of data; in 2015 it was Bangladesh ahead.
Bangladesh ranks 62nd and Cyprus ranks 59th of 194 countries.
Bangladesh has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bangladesh | Cyprus | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.7% | 0.6% | 0.1% | Bangladesh |
| 2020s | 0.5% | 0.5% | 0.0% | Bangladesh |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Bangladesh or Cyprus?
- Cyprus, at 0.5% against 0.4% in Bangladesh as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Bangladesh and Cyprus?
- 0.1%, with Cyprus ahead.
- How many years of comparable data are there for Bangladesh and Cyprus?
- 10 years are reported by both, from 2015 to 2024.
- How do Bangladesh and Cyprus rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Bangladesh ranks 62nd and Cyprus ranks 59th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.